These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients. Zhang Y; Guallar E; Blasco-Colmenares E; Butcher B; Norgard S; Nauffal V; Marine JE; Eldadah Z; Dickfeld T; Ellenbogen KA; Tomaselli GF; Cheng A J Am Coll Cardiol; 2015 Aug; 66(5):524-31. PubMed ID: 26227190 [TBL] [Abstract][Full Text] [Related]
25. The role of variability in night-time mean heart rate on the prediction of ventricular arrhythmias and all-cause mortality in implantable cardioverter defibrillator patients. Zhao S; Chen K; Su Y; Hua W; Pu J; Li H; Dai Y; Tang M; Fan X; Zhao Y; Zheng X; Cai C; Li Z; Zhang S Europace; 2015 Oct; 17 Suppl 2():ii76-82. PubMed ID: 26842120 [TBL] [Abstract][Full Text] [Related]
26. Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators. Sadarmin PP; Wong KC; Rajappan K; Bashir Y; Betts TR Europace; 2014 Nov; 16(11):1575-9. PubMed ID: 24668515 [TBL] [Abstract][Full Text] [Related]
27. Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study. Clementy N; Challal F; Marijon E; Boveda S; Defaye P; Leclercq C; Deharo JC; Sadoul N; Klug D; Piot O; Gras D; Bordachar P; Algalarrondo V; Fauchier L; Babuty D; Heart Rhythm; 2017 Feb; 14(2):211-217. PubMed ID: 27989789 [TBL] [Abstract][Full Text] [Related]
28. Cardiac MRI and radionuclide ventriculography for measurement of left ventricular ejection fraction in ICD candidates. Kotha VK; Deva DP; Connelly KA; Freeman MR; Yan RT; Mangat I; Kirpalani A; Barfett JJ; Sloninko J; Lin HM; Graham JJ; Crean AM; Jimenez-Juan L; Dorian P; Yan AT Magn Reson Imaging; 2018 Oct; 52():69-74. PubMed ID: 29859946 [TBL] [Abstract][Full Text] [Related]
29. Fragmented QRS and mortality risk in patients with left ventricular dysfunction. Cheema A; Khalid A; Wimmer A; Bartone C; Chow T; Spertus JA; Chan PS Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):339-44. PubMed ID: 20511537 [TBL] [Abstract][Full Text] [Related]
30. Syncope in high-risk cardiomyopathy patients with implantable defibrillators: frequency, risk factors, mechanisms, and association with mortality: results from the multicenter automatic defibrillator implantation trial-reduce inappropriate therapy (MADIT-RIT) study. Ruwald MH; Okumura K; Kimura T; Aonuma K; Shoda M; Kutyifa V; Ruwald AC; McNitt S; Zareba W; Moss AJ Circulation; 2014 Feb; 129(5):545-52. PubMed ID: 24201303 [TBL] [Abstract][Full Text] [Related]
31. Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction. Rijnierse MT; Allaart CP; de Haan S; Harms HJ; Huisman MC; Beek AM; Lammertsma AA; van Rossum AC; Knaapen P Heart; 2016 Jun; 102(11):832-40. PubMed ID: 26843532 [TBL] [Abstract][Full Text] [Related]
32. Heart rate predicts outcomes in an implantable cardioverter-defibrillator population. Ahmadi-Kashani M; Kessler DJ; Day J; Bunch TJ; Stolen KQ; Brown S; Sbaity S; Olshansky B; Circulation; 2009 Nov; 120(21):2040-5. PubMed ID: 19901194 [TBL] [Abstract][Full Text] [Related]
33. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population. Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719 [TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study. Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523 [TBL] [Abstract][Full Text] [Related]
35. Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients With Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death. House CM; Nguyen D; Thomas AJ; Nelson WB; Zhu DW J Card Fail; 2016 Feb; 22(2):125-32. PubMed ID: 26522819 [TBL] [Abstract][Full Text] [Related]
36. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy. Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044 [TBL] [Abstract][Full Text] [Related]
37. Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation. Thibodeau JB; Pillarisetti J; Khumri TM; Jones PG; Main ML Am J Cardiol; 2008 Mar; 101(6):861-4. PubMed ID: 18328854 [TBL] [Abstract][Full Text] [Related]